Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Six Week, Randomized, Double-Blind Placebo-Controlled, Suvorexant Augmentation Study of Antidepressant Treatment of Major Depressive Disorder With Residual Insomnia

NCT02669030 is registered in ClinicalTrials.gov with Institute for Advanced Medical Research, Alpharetta, GA as lead sponsor.

NCT NCT02669030
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02669030 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Six Week, Randomized, Double-Blind Placebo-Controlled, Suvorexant Augmentation Study of Antidepressant Treatment of Major Depressive Disorder With Residual Insomnia
Lead sponsor
Institute for Advanced Medical Research, Alpharetta, GA
Phase
Phase 4
Overall status
Unknown status
Start date
March 1, 2017
Completion date
December 31, 2019
Enrollment
74 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

depression, insomnia, major depressive disorder, mdd